United Kingdom

The cannabis market: helping investors navigate the UK regulatory regime

Matthew Townsend

Last year the global legal cannabis market was estimated to be worth USD12 billion but it is tipped to rise to over USD166 billion by 2025. Liberalisation of the legal framework for cannabis is a significant driver for this growth. Since 1 November 2018, the UK has joined the ranks of over 30 countries legalising Read More

UK High Court orders pre-action delivery up of samples for infringement testing and considers use in other jurisdictions

Rafi Allos

In Boehringer Ingelheim v Generics,* the English High Court ordered the rarely-used remedy of pre-action inspection of property, for the purpose of allowing experiments needed to assess patent infringement. The case provides a useful reminder of the powers of the Court in this area, as well as providing a reference as to how the Court Read More

MHRA provides further guidance on no-deal Brexit plans

Jacqueline Bore

The MHRA has issued updated guidance on its plans for the regulation of medicines, medical devices and clinical trials in the event that the United Kingdom leaves the European Union on 29 March 2019 without any agreement on its future relationship with the EU and, therefore, without any transitional period. The guidance reflects responses to Read More

New formulations of existing active substances are not entitled to an SPC according to Advocate-General

Toby Sears

The Opinion of Advocate General Saugmandsgaard Øe in Abraxis Bioscience (Case C-443/17) was delivered on 13 December 2018.  The Advocate General concluded  that the UK Intellectual Property Office had been  correct in declining to grant a Supplementary Protection Certificate (SPC)  to Abraxis for a novel formulation of an active substance which had already been the Read More

Rethinking the Growth Capital Challenge in UK Life Sciences

Matthew Appleton

Investors, entrepreneurs and deal makers in the UK Life Sciences industry met on the 28 September 2018 to share ideas on how to close the funding gap which exists for UK businesses in the period between early stage investment and IPO. At a lively panel discussion sponsored by LSX Connect and hosted by Allen & Read More